Matches in SemOpenAlex for { <https://semopenalex.org/work/W2505781983> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2505781983 abstract "In order to improve the therapeutic responses to immunotherapies in glioblastoma (GBM) patients, a known pharmaceutical, ritanserin, was repurposed to augment cytotoxic T cell responses and suppress tumor growth. To determine the kinetics of the immune response to GBM, the transplantable syngeneic glioma cell line GL261 was used in C57BL/6 mice to assess the tumor immune response in the brain, spleen, and cervical lymph node via flow cytometry weekly for one month. After identifying the optimal T cell response temporally, mice with established tumors were treated with 100mg/kg of Ritanserin for one week and harvested post treatment. Ritanserin is able to inhibit the activity of diacylglycerol kinase alpha (DGKA), an enzyme that converts diacylglycerol to phosphatidic acid, and can inhibit tumor growth in mice. In addition, DGKA is expressed in T cells, and is more highly expressed in those that have entered an unresponsive (anergic) state, characteristic of dysfunctional T cell responses to tumors. To determine if ritanserin can counteract T cell anergy, T cell responses were determined by assessment of T cell number by subset (CD8+, CD4+, CD4+FoxP3+), by activation (CD62L-CD44+), and by tumor-specific response to ovalbumin-expressing GL261 tumor cells in the brain, spleen, and cervical lymph nodes. In comparison to mock-injected mice, tumor-bearing mice showed a robust T cell response to tumors in the brain, peaking at days 21 and 28 post injection. Treatment with ritanserin resulted in a trend toward increased number and activation of T cells in the brain compared to vehicle-treated mice. In addition, there was a significant increase in OVA-specific T cells in the brain with treatment. In conclusion, T cells respond robustly to brain tumors in mice, and ritanserin treatment appears to increase this response by increased activation and priming of tumor-specific T cells. This indicates that ritanserin may have combinatorial effects on T cells when combined with checkpoint inhibitors such as ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1). Future experiments will focus on combining ritanserin and other repurposed drugs with these checkpoint inhibitors and further characterizing the effect of ritanserin on T cells. Citation Format: Breanna R. Brenneman, Desiree H. Floyd, Tajie Harris, Benjamin Purow. Assessing and augmenting the immune response to glioblastoma using repurposed pharmaceuticals. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 542." @default.
- W2505781983 created "2016-08-23" @default.
- W2505781983 creator A5002993465 @default.
- W2505781983 creator A5037423758 @default.
- W2505781983 creator A5076042525 @default.
- W2505781983 creator A5081571374 @default.
- W2505781983 date "2016-07-15" @default.
- W2505781983 modified "2023-09-27" @default.
- W2505781983 title "Abstract 542: Assessing and augmenting the immune response to glioblastoma using repurposed pharmaceuticals" @default.
- W2505781983 doi "https://doi.org/10.1158/1538-7445.am2016-542" @default.
- W2505781983 hasPublicationYear "2016" @default.
- W2505781983 type Work @default.
- W2505781983 sameAs 2505781983 @default.
- W2505781983 citedByCount "0" @default.
- W2505781983 crossrefType "proceedings-article" @default.
- W2505781983 hasAuthorship W2505781983A5002993465 @default.
- W2505781983 hasAuthorship W2505781983A5037423758 @default.
- W2505781983 hasAuthorship W2505781983A5076042525 @default.
- W2505781983 hasAuthorship W2505781983A5081571374 @default.
- W2505781983 hasConcept C126322002 @default.
- W2505781983 hasConcept C154317977 @default.
- W2505781983 hasConcept C167672396 @default.
- W2505781983 hasConcept C170493617 @default.
- W2505781983 hasConcept C202751555 @default.
- W2505781983 hasConcept C203014093 @default.
- W2505781983 hasConcept C2776090121 @default.
- W2505781983 hasConcept C2776885963 @default.
- W2505781983 hasConcept C2777450907 @default.
- W2505781983 hasConcept C2778122271 @default.
- W2505781983 hasConcept C2780849966 @default.
- W2505781983 hasConcept C2780931953 @default.
- W2505781983 hasConcept C502942594 @default.
- W2505781983 hasConcept C55493867 @default.
- W2505781983 hasConcept C71924100 @default.
- W2505781983 hasConcept C86803240 @default.
- W2505781983 hasConcept C8891405 @default.
- W2505781983 hasConcept C98274493 @default.
- W2505781983 hasConceptScore W2505781983C126322002 @default.
- W2505781983 hasConceptScore W2505781983C154317977 @default.
- W2505781983 hasConceptScore W2505781983C167672396 @default.
- W2505781983 hasConceptScore W2505781983C170493617 @default.
- W2505781983 hasConceptScore W2505781983C202751555 @default.
- W2505781983 hasConceptScore W2505781983C203014093 @default.
- W2505781983 hasConceptScore W2505781983C2776090121 @default.
- W2505781983 hasConceptScore W2505781983C2776885963 @default.
- W2505781983 hasConceptScore W2505781983C2777450907 @default.
- W2505781983 hasConceptScore W2505781983C2778122271 @default.
- W2505781983 hasConceptScore W2505781983C2780849966 @default.
- W2505781983 hasConceptScore W2505781983C2780931953 @default.
- W2505781983 hasConceptScore W2505781983C502942594 @default.
- W2505781983 hasConceptScore W2505781983C55493867 @default.
- W2505781983 hasConceptScore W2505781983C71924100 @default.
- W2505781983 hasConceptScore W2505781983C86803240 @default.
- W2505781983 hasConceptScore W2505781983C8891405 @default.
- W2505781983 hasConceptScore W2505781983C98274493 @default.
- W2505781983 hasLocation W25057819831 @default.
- W2505781983 hasOpenAccess W2505781983 @default.
- W2505781983 hasPrimaryLocation W25057819831 @default.
- W2505781983 hasRelatedWork W1259279500 @default.
- W2505781983 hasRelatedWork W2013226620 @default.
- W2505781983 hasRelatedWork W206211393 @default.
- W2505781983 hasRelatedWork W2090475773 @default.
- W2505781983 hasRelatedWork W2236857445 @default.
- W2505781983 hasRelatedWork W2304213956 @default.
- W2505781983 hasRelatedWork W2477053066 @default.
- W2505781983 hasRelatedWork W2481519667 @default.
- W2505781983 hasRelatedWork W2506571864 @default.
- W2505781983 hasRelatedWork W2566317271 @default.
- W2505781983 hasRelatedWork W2740769512 @default.
- W2505781983 hasRelatedWork W2741104222 @default.
- W2505781983 hasRelatedWork W2913282972 @default.
- W2505781983 hasRelatedWork W2955470036 @default.
- W2505781983 hasRelatedWork W2956922957 @default.
- W2505781983 hasRelatedWork W3081641895 @default.
- W2505781983 hasRelatedWork W3082478499 @default.
- W2505781983 hasRelatedWork W3083110487 @default.
- W2505781983 hasRelatedWork W3180806010 @default.
- W2505781983 hasRelatedWork W3213797988 @default.
- W2505781983 isParatext "false" @default.
- W2505781983 isRetracted "false" @default.
- W2505781983 magId "2505781983" @default.
- W2505781983 workType "article" @default.